GlassScriptPhysician profile
Nancy Cristoforo
NPI 1215925136
$801.64
in general payments reported to CMS, 2019-2025
20 companies · $74.66 in 2025
The $74.66 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.16 · 2020: $30.20 · 2021: $11.60 · 2022: $171 · 2023: $172 · 2024: $258 · 2025: $74.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $185.89 | 2023-2024 | Lifevest |
| Boston Scientific Corporation | $93.71 | 2019-2025 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $67.37 | 2022 | |
| Merck Sharp & Dohme LLC | $63.11 | 2023-2025 | Capvaxive, Recarbrio, Zerbaxa |
| Janssen Biotech, INC. | $41.91 | 2019 | |
| Averitas Pharma INC. | $41.83 | 2024 | Qutenza |
| Impulse Dynamics (USA) INC. | $40.15 | 2022 | |
| Pfizer INC. | $33.73 | 2021-2023 | |
| Biosense Webster, INC. | $30.20 | 2020 | |
| Edwards Lifesciences Corporation | $24.18 | 2023 | Sapien 3 Ultra Resilia |
| Eisai INC. | $23.38 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $21.32 | 2023 | Austedo Xr |
| Astrazeneca Pharmaceuticals LP | $20.66 | 2023 | |
| Novartis Pharmaceuticals Corporation | $20.48 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.19 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $17.76 | 2022 | |
| Exact Sciences Corporation | $16.66 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $14.46 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.08 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Cristoforo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.